Effects of MEK Inhibitor on Receptor Expression After Stroke
Author Information
Author(s): Aida Maddahi, Lars Edvinsson
Primary Institution: Lund University
Hypothesis
Blocking the transcriptional upregulation of endothelin, serotonin, and angiotensin receptors would reduce the cerebral infarct that occurs after focal cerebral ischemia.
Conclusion
The study shows that MCAO leads to increased expression of certain vascular receptors, and using a MEK1 inhibitor can reduce this expression and the associated brain damage.
Supporting Evidence
- MCAO resulted in an increase in the number of contractile smooth muscle receptors in the MCA and microvessels.
- Blockade of transcription with the MEK1 inhibitor reduced enhanced vascular receptor expression.
- The study demonstrated that treatment with U0126 significantly reduced infarct volume.
Takeaway
When the brain doesn't get enough blood, certain receptors go up, making things worse. A special medicine can help lower those receptors and protect the brain.
Methodology
Rats underwent 2 hours of middle cerebral artery occlusion followed by 48 hours of reperfusion, with receptor expression analyzed using immunohistochemistry and Western blot.
Potential Biases
Potential bias in the interpretation of results due to the use of a specific animal model.
Limitations
The study primarily used a single animal model and may not fully translate to human conditions.
Participant Demographics
Male Wistar-Hanover rats weighing approximately 300–350 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website